PharmX Technologies Limited (PHX.AX)
- Previous Close
0.0890 - Open
0.0890 - Bid 0.0880 x --
- Ask 0.0950 x --
- Day's Range
0.0860 - 0.0920 - 52 Week Range
0.0270 - 0.0920 - Volume
321,731 - Avg. Volume
459,266 - Market Cap (intraday)
55.063M - Beta (5Y Monthly) 0.90
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date Aug 19, 2025 - Aug 25, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Nov 28, 2023
- 1y Target Est
--
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering gateway; PharmX Marketplace, an online sales and marketing platform; and PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in Sydney, Australia.
pharmx.com.au--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: PHX.AX
View MorePerformance Overview: PHX.AX
Trailing total returns as of 6/5/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHX.AX
View MoreValuation Measures
Market Cap
53.27M
Enterprise Value
48.97M
Trailing P/E
1.39k
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.61
Price/Book (mrq)
3.30
Enterprise Value/Revenue
7.00
Enterprise Value/EBITDA
33.18
Financial Highlights
Profitability and Income Statement
Profit Margin
1.37%
Return on Assets (ttm)
0.55%
Return on Equity (ttm)
0.09%
Revenue (ttm)
8.63M
Net Income Avi to Common (ttm)
14k
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
4.48M
Total Debt/Equity (mrq)
1.16%
Levered Free Cash Flow (ttm)
-8.34M